GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Cyclically Adjusted Revenue per Share

Bayer AG (XTER:BAYN) Cyclically Adjusted Revenue per Share : €54.36 (As of Dec. 2023)


View and export this data going back to 1953. Start your Free Trial

What is Bayer AG Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Bayer AG's adjusted revenue per share for the three months ended in Dec. 2023 was €12.074. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €54.36 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Bayer AG's average Cyclically Adjusted Revenue Growth Rate was 1.30% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 3.90% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 2.50% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was 1.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Bayer AG was 3.90% per year. The lowest was 0.30% per year. And the median was 2.10% per year.

As of today (2024-04-27), Bayer AG's current stock price is €27.40. Bayer AG's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was €54.36. Bayer AG's Cyclically Adjusted PS Ratio of today is 0.50.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 3.18. The lowest was 0.48. And the median was 1.53.


Bayer AG Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Bayer AG's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bayer AG Cyclically Adjusted Revenue per Share Chart

Bayer AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.23 48.50 50.17 53.64 54.36

Bayer AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.64 54.93 54.82 54.87 54.36

Competitive Comparison of Bayer AG's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - General subindustry, Bayer AG's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bayer AG's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bayer AG's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bayer AG's Cyclically Adjusted PS Ratio falls into.



Bayer AG Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Bayer AG's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=12.074/123.6675*123.6675
=12.074

Current CPI (Dec. 2023) = 123.6675.

Bayer AG Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 12.758 99.543 15.850
201406 12.342 99.543 15.333
201409 12.067 99.823 14.949
201412 13.071 99.543 16.239
201503 14.426 99.717 17.891
201506 14.437 100.417 17.780
201509 13.328 100.417 16.414
201512 13.635 99.717 16.910
201603 14.335 100.017 17.725
201606 14.309 100.717 17.570
201609 9.986 101.017 12.225
201612 10.390 101.217 12.695
201703 11.109 101.417 13.546
201706 9.844 102.117 11.921
201709 9.062 102.717 10.910
201712 9.707 102.617 11.698
201803 10.319 102.917 12.400
201806 10.354 104.017 12.310
201809 9.449 104.718 11.159
201812 10.560 104.217 12.531
201903 12.500 104.217 14.833
201906 10.912 105.718 12.765
201909 10.006 106.018 11.672
201912 10.942 105.818 12.788
202003 13.075 105.718 15.295
202006 10.234 106.618 11.871
202009 8.658 105.818 10.118
202012 10.174 105.518 11.924
202103 12.549 107.518 14.434
202106 11.048 108.486 12.594
202109 9.956 109.435 11.251
202112 11.317 110.384 12.679
202203 14.901 113.968 16.169
202206 13.048 115.760 13.939
202209 11.483 118.818 11.952
202212 12.215 119.345 12.657
202303 14.646 122.402 14.797
202306 11.242 123.140 11.290
202309 10.527 124.195 10.482
202312 12.074 123.668 12.074

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Bayer AG  (XTER:BAYN) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Bayer AG's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=27.40/54.36
=0.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Bayer AG was 3.18. The lowest was 0.48. And the median was 1.53.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Bayer AG Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Bayer AG's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Bayer AG (XTER:BAYN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bayer AG (XTER:BAYN) » Definitions » Cyclically Adjusted Revenue per Share
Address
Kaiser-Wilhelm-Allee 1, Leverkusen, NW, DEU, 51368
Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

Bayer AG (XTER:BAYN) Headlines